Related Posts
Monthly Archives
February 2023
Indian Pharma Network helps in accessing new products in India. These products are launched and approved recently in USA or Europe but yet to be approved in India. We help in accessing these new launches through named patient import.
QUICK LINKS
ABOUT US
Indian Pharma Network facilitates patients connecting with genuine pharmaceutical suppliers, wholesalers and dealers.
Indian Pharma Network.
CORPORATE OFFICE
Indian Pharma Network.
905 – 9th Floor, I-Thum Business Park,
Tower A, Plot no. A-40, Unit no. 5,
Sector-62, Noida 201301,
© 2025 Indian Pharma Network - Buy prescriptions drugs.
Close Menu
- Home
- About Us
- Product List
- ONCOLOGY
- Lunsumio (Mosunetuzumab-axgb)
- Krazati (adagrasib)
- Rolvedon (Eflapegrastim-xnst)
- Orserdu (Elacestrant)
- Ocaliva (Obeticholic Acid)
- Portrazza (Necitumumab)
- Cytalux (Pofalacianine)
- Pylarify (Piflufolastat F18)
- Truseltiq (Infigratinib)
- Enhertu (Trastuzumab Deruxtecan)
- Mektovi (Binimetinib)
- Braftovi (Encorafenib)
- Libtayo (Cemiplimab-rwlc)
- Lorbrena (Lorlatinib)
- Talzenna (Talazoparib)
- Balversa (Erdafitinib)
- Piqray (Alpelisib)
- Alunbrig (Brigatinib)
- Jemperli (Dostarlimab-gxly)
- Tepmetko (Tepotinib)
- COSELA (Trilaciclib)
- Fotivda (Tivozanib)
- Rozlytrek (Entrectinib)
- Tivdak® (tisotumab vedotin-tftv)
- Ayvakit (Avapritinib)
- Tazverik (Tazemetostat)
- Tukysa (Tucatinib)
- Pemazyre (Pemigatinib)
- Trodelvy (Sacituzumab govitecan-hziy)
- Tabrecta (Capmatinib)
- Retevmo (Selpercatinib)
- Zepzelca (Lurbinectedin)
- Gavreto (Pralsetinib)
- MARGENZATM (margetuximab-cmkb)
- Orgovyx (relugolix)
- DANYELZA (naxitamab-gqgk)
- ZEJULA (Niraparib)
- VERZENIO (Abemaciclib)
- TECENTRIQ (Atezolizumab)
- NERLYNX (Neratinib)
- Yervoy
- CAPRELSA (Vandetnib)
- CELSENTRI (Maraviroc)
- CIDOFOVIR (Visitide)
- IBRANCE (Palbociclib Capsules)
- COMETRIQ (Cabozantinib)
- CYRAMZA (Ramucirumab Injection)
- DABRAFENIB (Tafinlar)
- ENTEREG (Almiopan Capsule)
- ERIVEDGE (Vismodegib Tablet)
- LYNPARZA (Olaparib)
- Qinlock (Ripretinib)
- MEKINIST (Trametnib Tablet)
- Mitotane (Lysodren)
- NAVELBINE ORAL (Vinorelbine)
- TEYSUNO (Tegafur)
- ZELBORAF (Vemurafenib Tablet)
- Zepzelca (Lurbinectedin)
- ZYDELIG (Idelalisib)
- HEMATOLOGY
- Rezlidhia (Olutasidenib)
- Jaypirca(pirtobrutinib)
- Jesduvroq (Daprodustat)n
- Columvi (Glofitamab-gxbm)
- Feraccru (Ferric Maltol)
- Adakveo (Crizanlizumab-tmca)
- Andexxa (Ondexxya)
- Loqtorzi (toripalimab-tpzi)
- Evrenzo (Roxadustat)
- Ninlaro (Ixazomib)
- Cablivi (Caplacizumab-yhdp)
- Rezurock (Belumosudil)
- Empaveli (Pegcetacoplan)
- Idhifa (Enasidenib)
- Besponsa (Inotuzumab Ozogamicin)
- Tibsovo (Ivosidenib)
- Poteligeo (Mogamulizumab-kpkc)
- Xospata (Gilteritinib)
- Asparlas (Calaspargase pegol-mknl)
- Polivy (Polatuzumab Vedotin-piiqa
- Reblozyl (Luspatercept–aamt)
- Ukoniq (Umbralisib)
- Pepaxto (Melphalan Flufenamide)
- Zynlonta (Loncastuximab Tesirine-lpyl)
- Rylaze
- Exkivity (Mobocertinib)
- SCEMBLIX®(Asciminib)
- Besremi (Ropeginterferon alfa-2b-njft)
- SARCLISA® (isatuximab-irfc)
- Inqovi (decitabine and cedazuridine)
- Blenrep (Belantamab Mafodotin-blmf)
- Monjuvi (Tafasitamab-cxix)
- TAFINLAR (Dabrafenib)
- CALQUENCE (Acalabrutinib)
- MYLOTARG Gemtuzumab
- Aliqopa(Copanlisib)
- Brentuximab Vedotin
- AGRYLIN (Anagrelide Hydrochloride)
- ATRIANCE (Nelarabine)
- BLINCYTO (Blinatumomab)
- ONCASPAR (Pegaspargase)
- ERWINAZE (Asparaginase Erwinia Chrysanthemi)
- FOLOTYN (Pralatrexate)
- TREOSULFAN (Treosulfan)
- Ponatinib
- NPLATE (Romiplostim)
- KYPROLIS (Carfilzomib)
- MABCAMPATH (Alemtuzumab)
- VENCLEXTA (Venetoclax)
- SOLIRIS (eculizumab)
- SYNRIBO (Omacetaxine Mepesuccinate)
- ALKERAN (Melphalan)
- FARYDAK (Panobinostat)
- BOSULIF (Bosutinib)
- ELDISINE (Vindesine Sulphate)
- Ixazomib Citrate
- TEPADINA (Thiotepa)
- ZOLINZA (Vorinostat)
- NEUROLOGY
- Radicut (Edaravone)
- Rilutek (Riluzole)
- Ajovy (Fremanezumab-vfrm)
- Emgality (Galcanezumab)
- Fycompa (Perampanel)
- Azstarys (Serdexmethylphenidate and Dexmethylphenidate)
- Qelbree (Viloxazine)
- Lybalvi (Olanzapine and Samidorphan)
- Aduhelm (aducanumab-avwa)
- NUEDEXTA (Dextromethorphan Hydrobromide)
- ILARIS (Canakinumab)
- GLIOLAN (Aminolevulinic acid hydrochloride)
- STELARA (Ustekinumab)
- HUMIRA (Adalimumab)
- IMMUNOLOGY
- MISC.
- Daybue(Trofinetide)
- Sotyktu (Deucravacitinib)
- Orilissa (Elagolix)
- Vitrakvi (Larotrectinib)
- Imjudo (Tremelimumab)
- Leqvio (Inclisiran)
- Livmarli (Maralixibat)
- Saphnelo (anifrolumab-fnia)
- Nextstellis (Drospirenone and Estetrol)
- Brexafemme (Ibrexafungerp)
- Qulipta Atogepant
- Zemdri (Plazomicin)
- Epidiolex (Cannabidiol)
- ZAVICEFTA (Avibactum + Ceftazidime)
- BAXDELA (Delafloxacin)
- BEVYXXA (Betrixaban)
- FASENRA (Benralizumab)
- FIRAZYR (Icatibant)
- KEVZARA(Sarilumab)
- TRULANCE (Plecanatide)
- VIVITROL (Naltrexone)
- XADAGO (Safinamide)
- Foscavir (Foscarnet sodium injection)
- Anakinra (Kineret)
- PADCEV (Enfortumab Vedotin-ejfv)
- Lonsurf (Trifluridine/Tipiracil)
- Dantrium IV (Dantrolene Sodium)
- Ngenla (Somatrogon-ghla)
- Vanflyta (Quizartinib)
- Beyfortus (Nirsevimab)
- RARE DISEASES
- Uplizna (Inebilizumab-cdon)
- Strensiq (Asfotase alfa)
- Tavneos (Avacopan)
- Skytrofa (Lonapegsomatropin-tcgd)
- Nexviazyme (Avalglucosidase alfa-ngpt
- Evkeeza (Evinacumab-dgnb)
- Nulibry (Fosdenopterin)
- Welireg (Belzutifan)
- Xiaflex (Collagenase Clostridium Histolyticum)
- Mepsevii (Vestronidase alfa-vjbk)
- Symdeko (Tezacaftor/Ivacaftor & Ivacaftor)
- Palynziq (Pegvaliase-pqpz)
- Onpattro (Patisiran)
- Galafold (Migalastat)
- Diacomit (Stiripentol)
- Takhzyro (Lanadelumab)
- Orfadin (Nitisinone)
- Trikafta (elexacaftor, tezacaftor and ivacaftor)
- Spinraza (Nusinersen)
- Amondys 45 (Casimersen)
- Voxzogo (Vosoritide)
- Tepezza (Teprotumumab-trbw)
- Isturisa (Osilodrostat)
- Koselugo (Selumetinib)
- VILTEPSO (Viltolarsen)
- XERMELO (Telotristat)
- BRINUERA(Cerliponase alfa)
- MEPSEVII (Vestronidase)
- PARSABIV (Etelcalcetide)
- RADICAVA (Edaravone)
- RHOPRESSA (Netarsudil)
- Nephrology
- GASTROENTROLOGY
- Cardio
- ONCOLOGY
- Blog
- News
- Contact Us
- +91 9810469557